Xeris Biopharma Holdings, Inc. (XERS)
7.00
-0.05
(-0.71%)
USD |
NASDAQ |
Dec 16, 12:21
Xeris Biopharma Holdings Research and Development Expense (TTM): 29.38M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Amneal Pharmaceuticals, Inc. | 205.62M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |